Shares of Tempus AI, Inc. (NASDAQ:TEM - Get Free Report) were down 4.4% during trading on Thursday . The stock traded as low as $46.09 and last traded at $46.20. Approximately 283,319 shares traded hands during trading, a decline of 76% from the average daily volume of 1,176,824 shares. The stock had previously closed at $48.33.
Wall Street Analyst Weigh In
Several equities analysts have issued reports on TEM shares. JPMorgan Chase & Co. lifted their price target on shares of Tempus AI from $42.00 to $47.00 and gave the stock an "overweight" rating in a report on Wednesday, August 7th. William Blair assumed coverage on Tempus AI in a research report on Tuesday, July 9th. They set an "outperform" rating on the stock. Loop Capital assumed coverage on Tempus AI in a report on Tuesday, July 9th. They issued a "buy" rating and a $48.00 price target for the company. Piper Sandler initiated coverage on shares of Tempus AI in a report on Monday, August 12th. They set a "neutral" rating and a $40.00 price objective on the stock. Finally, Needham & Company LLC reiterated a "buy" rating and issued a $47.00 target price on shares of Tempus AI in a research note on Wednesday, August 7th. Two equities research analysts have rated the stock with a hold rating and eight have issued a buy rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $47.67.
View Our Latest Stock Analysis on TEM
Tempus AI Stock Performance
The company has a current ratio of 3.70, a quick ratio of 3.52 and a debt-to-equity ratio of 4.50. The firm has a 50 day moving average price of $51.22.
Tempus AI (NASDAQ:TEM - Get Free Report) last announced its earnings results on Tuesday, August 6th. The company reported ($6.77) earnings per share for the quarter, missing the consensus estimate of ($4.41) by ($2.36). The firm had revenue of $165.97 million during the quarter, compared to analyst estimates of $159.10 million. As a group, research analysts predict that Tempus AI, Inc. will post -6.51 earnings per share for the current year.
Institutional Inflows and Outflows
Hedge funds have recently added to or reduced their stakes in the company. Sandia Investment Management LP purchased a new stake in Tempus AI during the 2nd quarter valued at about $136,000. Northwestern University purchased a new stake in shares of Tempus AI in the second quarter valued at about $491,000. Squarepoint Ops LLC acquired a new stake in shares of Tempus AI during the 2nd quarter worth approximately $633,000. WINTON GROUP Ltd purchased a new position in Tempus AI in the second quarter worth approximately $634,000. Finally, Scientech Research LLC acquired a new stake in Tempus AI during the second quarter worth $756,000.
About Tempus AI
(
Get Free Report)
Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.
Read More
Before you consider Tempus AI, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tempus AI wasn't on the list.
While Tempus AI currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
